WDR5B inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the WDR5B protein, which is a member of the WD40 repeat-containing proteins. These proteins are essential in various cellular processes, including gene expression, chromatin remodeling, and protein-protein interactions. WDR5B is known for its role in the assembly and maintenance of chromatin complexes that regulate gene transcription. By inhibiting WDR5B, these compounds interfere with its ability to facilitate the recruitment of other proteins to chromatin, thereby modulating gene expression and chromatin dynamics. The inhibition of WDR5B is particularly significant in the regulation of epigenetic modifications, as WDR5B often interacts with histone-modifying enzymes.
The design and development of WDR5B inhibitors rely on a detailed understanding of the structural features of the WDR5B protein, especially its interaction domains. Inhibitors are crafted to bind precisely to the protein's active or binding sites, preventing it from associating with other components of the chromatin machinery. This selective targeting is crucial for ensuring that WDR5B inhibitors effectively disrupt its specific biological functions without affecting unrelated proteins. Researchers use techniques like structure-based drug design, molecular docking studies, and biochemical assays to refine the inhibitors' binding affinity and specificity. The effects of these inhibitors on cellular processes can be profound, as they can alter chromatin states, transcriptional profiles, and other downstream regulatory pathways linked to WDR5B's activity, making the study of WDR5B inhibition an important area for understanding fundamental biological mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This agent could demethylate the WDR5B gene promoter, leading to transcriptional repression and consequent downregulation of the protein's synthesis. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
By inhibiting DNA methyltransferase when incorporated into DNA, 5-Aza-2′-Deoxycytidine may specifically reduce WDR5B gene expression through promoter demethylation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid may facilitate histone acetylation, potentially leading to a condensed chromatin state around the WDR5B locus and subsequent decrease in its mRNA production. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This compound can enhance acetylation of histones associated with the WDR5B gene, potentially causing transcriptional silencing and a decrease in protein expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A could bind selectively to the WDR5B gene's promoter region, obstructing the binding of essential transcription factors and thereby decreasing gene translation. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide might repress the transcriptional activity of RNA polymerase II at the WDR5B gene, leading to a stark reduction in its RNA and protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
By intercalating into DNA, Actinomycin D could directly inhibit RNA polymerase movement during mRNA synthesis of WDR5B, leading to reduced transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin may specifically inhibit the mTOR pathway, which is potentially involved in the translation of WDR5B mRNA, resulting in lowered protein levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As an inhibitor of the PI3K pathway, LY 294002 could lead to the downregulation of the downstream protein synthesis machinery, including that of WDR5B. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram could disrupt cellular acetyl-CoA metabolism, potentially leading to altered histone acetylation patterns and decreased expression of WDR5B. | ||||||